We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of rifampicin and graft removal are associated with better outcomes in prosthetic vascular graft infection.
- Authors
Coste, Anne; Poinot, Mélanie; Panaget, Sophie; Albert, Bénédicte; Kaladji, Adrien; Le Bars, Hervé; Bahaa, Nasr; Ali, Badra; Piau, Caroline; Cattoir, Vincent; de Moreuil, Claire; Revest, Matthieu; Le Berre, Rozenn
- Abstract
Objectives: Prosthetic vascular graft infection (PVGI) is a very severe disease. We aimed to determine the factors associated with treatment failure. Methods: Patients admitted to two University Hospitals with PVGI were included in this retrospective study. PVGI was classified as possible, probable or proven according to an original set of diagnostic criteria. We defined treatment failure if one of the following events occurred within the first year after PVGI diagnosis: death and infection recurrence due to the same or another pathogen. Results: One hundred and twelve patients were diagnosed with possible (n = 26), probable (n = 22) and proven (n = 64) PVGI. Bacterial documentation was obtained for 81% of patients. The most frequently identified pathogen was Staphylococcus aureus (n = 39). Surgery was performed in 96 patients (86%). Antibiotics were administered for more than 6 weeks in 41% of patients. Treatment failure occurred in 30 patients (27.5%). The factors associated with a lower probability of treatment failure were total removal of the infected graft (OR = 0.2, 95% CI [0.1–0.6]), rifampicin administration (OR = 0.3 [0.1–0.9]) and possible PVGI according to the GRIP criteria (OR = 0.3 [0.1–0.9]). Conclusions: Treatment failure occurred in 27.5% of patients with PVGI. Total removal of the infected graft and rifampicin administration were associated with better outcomes.
- Subjects
ANTIBIOTICS; ACADEMIC medical centers; CONFIDENCE intervals; INFECTION; COMPLICATIONS of prosthesis; RIFAMPIN; OPERATIVE surgery; TRANSPLANTATION of organs, tissues, etc.; DISEASE relapse; TREATMENT effectiveness; RETROSPECTIVE studies; DESCRIPTIVE statistics; ODDS ratio
- Publication
Infection, 2021, Vol 49, Issue 1, p127
- ISSN
0300-8126
- Publication type
Article
- DOI
10.1007/s15010-020-01551-z